Small molecules in combination with conventional chemotherapeutic drugs: Light at the end of the tunnel?
Authors:
Open Access
- 28 August 2012
- journal article
- Published by Spandidos Publications in Oncology Letters
- Vol. 4 (5) , 1043-1046
Abstract
Recent studies have shown BI2536 and bortezomib to be effective in squamous cell carcinoma of the head and neck (SCCHN) cell lines. In this systemic in vitro study, we examined the antitumor effect of the small molecules BI2536 and bortezomib in combination with cisplatin or docetaxel in nine squamous cell carcinoma cell lines, most of head and neck origin. Dose escalation studies were performed with these cell lines using bortezomib, BI2536, cisplatin and docetaxel in cell line-specific concentrations. Growth inhibitory and proapoptotic effects were measured quantitatively using cytohistology and the Human Apoptosis Array kit. The combination of bortezomib and BI2536 with cisplatin or docetaxel showed a significantly higher antiproliferative and apoptotic activity in all SCCHN cell lines investigated compared with single agent cisplatin or docetaxel alone (P≤0.021). Combination of conventional chemotherapeutic drugs, such as cisplatin and docetaxel, with small molecules in the clinical setting may enhance the antitumor activity of these agents and may lead to less toxic side-effects and a more effective cancer therapy.Keywords
This publication has 20 references indexed in Scilit:
- CXCR3-B Can Mediate Growth-inhibitory Signals in Human Renal Cancer Cells by Down-regulating the Expression of Heme Oxygenase-1Journal of Biological Chemistry, 2010
- Head and neck cancer--Part 1: Epidemiology, presentation, and preventionBMJ, 2010
- Bitter Melon (Momordica charantia) Extract Inhibits Breast Cancer Cell Proliferation by Modulating Cell Cycle Regulatory Genes and Promotes ApoptosisCancer Research, 2010
- Cetuximab enhances the efficacy of bortezomib in squamous cell carcinoma cell linesJournal of Cancer Research and Clinical Oncology, 2008
- Cisplatin nephrotoxicity: Mechanisms and renoprotective strategiesKidney International, 2008
- Regulation of mitosis via mitotic kinases: new opportunities for cancer managementMolecular Cancer Therapeutics, 2007
- The proteasome: A worthwhile target for the treatment of solid tumours?European Journal of Cancer, 2007
- Targeting EGF-receptor-signalling in squamous cell carcinomas of the head and neckBritish Journal of Cancer, 2007
- Targeting polo-like kinase 1 for cancer therapyNature Reviews Cancer, 2006
- Proteasome Inhibitor PS-341 Induces Apoptosis through Induction of Endoplasmic Reticulum Stress-Reactive Oxygen Species in Head and Neck Squamous Cell Carcinoma CellsMolecular and Cellular Biology, 2004